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Abstract
Background: Gum of Chios mastic (Pistacia lentiscus var. chia) is a natural antimicrobial agent that has found
extensive use in pharmaceutical products and as a nutritional supplement. The molecular mechanisms of its anti-
inflammatory activity, however, are not clear. In this work, the potential role of antioxidant activity of Chios mastic
gum has been evaluated.
Methods: Scavenging of superoxide radical was investigated by electron spin resonance and spin trapping
technique using EMPO spin trap in xanthine oxidase system. Superoxide production in endothelial and smooth
muscle cells stimulated with TNF-a or angiotensin II and treated with vehicle (DMSO) or mastic gum (0.1-10 μg/ml)
was measured by DHE and HPLC. Cellular H2O2 was measured by Amplex Red. Inhibition of protein kinase C (PKC)
with mastic gum was determined by the decrease of purified PKC activity, by inhibition of PKC activity in cellular
homogenate and by attenuation of superoxide production in cells treated with PKC activator phorbol 12-myristate
13-acetate (PMA).
Results: Spin trapping study did not show significant scavenging of superoxide by mastic gum itself. However,
mastic gum inhibited cellular production of superoxide and H2O2 in dose dependent manner in TNF-a treated rat
aortic smooth muscle cells but did not affect unstimulated cells. TNF-a significantly increased the cellular
superoxide production by NADPH oxidase, while mastic gum completely abolished this stimulation. Mastic gum
inhibited the activity of purified PKC, decreased PKC activity in cell homogenate, and attenuated superoxide
production in cells stimulated with PKC activator PMA and PKC-dependent angiotensin II in endothelial cells.
Conclusion: We suggest that mastic gum inhibits PKC which attenuates production of superoxide and H2O2 by
NADPH oxidases. This antioxidant property may have direct implication to the anti-inflammatory activity of the
Chios mastic gum.
Keywords: Inflammation, oxidative stress, antioxidant, Chios mastic gum, superoxide, hydrogen peroxide, protein
kinase C, NADPH oxidase, TNF-alpha, angiotensin II
Introduction
Chios Mastic gum is derived from Pistacia lentiscus var.
Chia cv. Anacardiaceae, a plant which is mainly met on
the greek island of Chios. The beneficial, healing proper-
ties of mastic gum have been known since antiquity [1].
From Dioscurides and Galenus to the ‘Jerusalem
Balsam’, Pistacia lentiscus has been traditionally consid-
ered as a medical agent and is incorporated in Mediter-
ranean cuisine, as a therapeutic means for hepatic
inflammation, for disorders of the stomach and intes-
tine, and beneficial for the teeth [2]. Nowadays, food
products (apart from the well-established chewing gum)
and cosmetics based on mastic have been created. Chios
mastic gum is consumed as chewing gum and also in
other culinary art usage, especially in Greek, Turkish
and Arabic kitchens, i.e. in the powder form as food
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sweetener and as mastic oil as a sweet additive in drinks.
It has been referred to over centuries as having medic-
inal properties to treat a variety of diseases. It has been
proven as a therapeutic agent against various gastric
malfunctions, such as gastralgia, dyspepsia and gastric
ulcer [3,4].
Clinical studies have emphasized anti-inflammatory
activity of Chios mastic gum [5,6]. This biological activ-
ity can be attributed to a variety of compounds. It con-
tains triterpenes of the oleanane, euphane and lupine
type [7,8]; alpha-tocopherol and polyphenols; the latter
have been associated with a hypotensive effect of mastic
[9]. Chios mastic possesses anti-bacterial activity [10,11],
for which verbenone, alpha-terpineol, and linalool seem
to be responsible.
Pistacia lentiscus has been traditionally regarded also
as an anti-cancer agent, especially on tumours of breast,
liver, stomach, spleen, and uterus. Surprisingly enough,
these traditional beliefs are in line with recent studies
demonstrating that Chios mastic induces apoptosis and
possesses antiproliferative activity in colon cancer cells
[12]. Pistacia lentiscus has already been associated with
cardiovascular protection and hepatoprotection [13]. It
inhibits human LDL oxidation and acts on peripheral
blood mononuclear cells to elicit an antiatherogenic
effect [14]. The aqueous extract from the leaves of Pista-
cia lentiscus demonstrated hepatoprotective effect in rats
intoxicated with carbon tetrachloride [15], which is well-
known for induction of oxidative stress. The antiathero-
genic activity and protection from carbon tetrachloride
t o x i c i t ya r el i k e l yt ob ea s s o c i a t e dw i t ha n t i o x i d a n t
properties of mastic gum. However, free radical scaven-
ging properties and antioxidant activity of mastic gum
has not been investigated.
Inflammation is strongly associated with oxidative
stress induced by TNF-a and angiotensin II [16]. Pro-
inflammatory cytokine TNF-a stimulates of superoxide
production by NADPH oxidases [17] which provides
feed-forward activation of inflammatory pathways [18].
We have hypothesized that anti-inflammatory activity of
Chios mastic gum is associated with its potential antiox-
idant activity. In this work, we have evaluated the free
radical scavenging and antioxidant activity of Chios
mastic gum on TNF-a and angiotensin II - induced
superoxide production. We found that mastic gum
inhibited superoxide production induced by both TNF-
a and angiotensin II, which may have direct implica-
tions for its physiological activity.
Materials and methods
Reagents
Mastic gum was obtained from Chios Mastiha Growers
Association (Chios, Greece) and dissolved in DMSO.
Typical mastic gum contained 40-55% triterpenic acids
and 20-25% polymer fraction (poly-b-myrcene).
Angiotensin II (Ang II), superoxide dismutase (SOD),
TNF-a, 12-myristate 13-acetate (PMA) and xanthine were
obtained from Sigma-Aldrich (St. Louis, MO). Xanthine
oxidase was purchased from Roche Molecular Biochem-
icals (Indianapolis, IN). 1-Hydroxy-3-carboxy-2,2,5,
5-tetramethyl-pyrrolidine (CPH) and 5-ethoxycarbonyl-
5-methyl-1-pyrroline N-oxide (EMPO) were purchased
from Enzo Life Sciences (Plymouth Meeting, PA). Dihy-
droethidium was purchased from Molecular Probes
(Eugene, OR).
Electron Spin Resonance (ESR) experiments
ESR experiments were carried out in 50 mM sodium
phosphate buffer (pH 7.4) with 0.9% NaCl and DTPA
(100 μM). ESR spectra were recorded at room tem-
perature using an EMX ESR spectrometer (Bruker
BioSpin, Massachusetts). EMPO samples ESR spectra
were recorded with the following settings: field sweep,
70 G; microwave frequency, 9.78 GHz; microwave
power, 40 mW; modulation amplitude, 0.7 G; conver-
sion time, 40.96 ms; time constant, 40.96 ms. Superox-
ide detection by CPH was performed by following the
low-field peak of the nitroxide ESR spectra using time
scans with the following settings: microwave frequency,
9.78 GHz; modulation amplitude, 2 G; microwave
power, 20 mW; conversion time, 1.3 s; time constant,
5.2 s.
Superoxide radical generation
The xanthine oxidase superoxide generating system con-
tained xanthine oxidase (20 mU/ml), xanthine (50 μM),
and DTPA (0.1 mM) in 50 mM sodium phosphate
buffer (pH 7.4) with 0.9% NaCl.
Simulation of ESR spectra
Computer simulation of experimental ESR spectra was
used for the calculation of hyperfine coupling constants.
Programs for the simulation of ESR spectra and the
spin-trap database are readily available to the public
through the Internet http://epr.niehs.nih.gov/[19].
Cell culture
Rat aortic smooth muscle cells (RASMC) were isolated
from rat aortas by enzymatic digestion as previously
described [20]. Quiescent cells were prepared in Dulbec-
co’s modified Eagle’s medium (DMEM) containing 10%
calf serum, 4.5 g/l glucose and 2 mM glutamine by
placing 70% confluent RASMC in serum-free media for
three days. Bovine aortic endothelial cells (BAEC, pas-
sage 4 to 8) were cultured in Media 199 containing 10%
fetal calf serum supplemented with 2 mM L-glutamine
and 1% vitamins. On the day before the study, the fetal
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cells were used for the experiments.
All animal use complied with National Institutes of
Health guidelines and was approved by the Emory Uni-
versity Institutional Animal Care and Use Committee.
Detection of intracellular superoxide with high-
performance liquid chromatography
To evaluate intracellular production of superoxide, we
measured the formation of 2-hydroxyethidium from
dihydroethidium (DHE) using high-performance liquid
chromatography (HPLC) analysis as recently reported
[21]. Medium was removed from cells platted on 100
mm dish and replaced with 10 μM DHE in fresh Krebs-
HEPES buffer. After 20 minute incubation at 37°C buf-
fer was aspirated, cells were collected into 300 μL
methanol, and cell homogenate was filtered via 0.2 μm
filter. Separation of ethidium, 2-hydroxyethidium, and
dihydroethidium was performed with the use of an acet-
onitrile gradient and a C-18 reverse-phase column
(Nucleosil 250-4.5 mm) on a Beckman HPLC system
with a fluorescence detector Jasco FP-2020 (Easton,
MD) using an emission wavelength of 580 nm and an
excitation of 480 nm.
Measurements of NADPH oxidase activity in
membrane fraction
The activity of NADPH oxidase was directly measured
by NADPH dependent O2* production in the membrane
fractions of RASMC prepared as described previously
[22].
Measurements of cellular H2O2
Production of cellular H2O2 was analyzed by Amplex
Red assay provided by Invitrogen (Carlsbad, CA) based
on conversion of Amplex Red (50 μM) into fluorescent
resorufin in the presence of horseradish peroxidase
(0.1 units/ml) after two hours incubation with cells [21].
The PKC Kinase Activity Assay
The PKC Kinase Activity Assay was obtained from Enzo
Life Sciences (Plymouth Meeting, PA). This is based on
a solid phase enzyme-linked immuno-absorbent assay
(ELISA) utilizing a specific synthetic peptide as a sub-
strate for PKC and a polyclonal antibody recognizing
the phosphorylated form of the substrate phosphory-
lated by PKC. ATP is added to initiate the reaction, and
kinase reaction is terminated by Phosphospecific Sub-
strate Antibody to bind specifically to the phosphory-
lated peptide substrate. The phosphospecific antibody is
subsequently bounded by a peroxidase conjugated sec-
ondary antibody. The assay is developed with tetra-
methylbenzidine substrate and a color develops in
proportion to PKC phosphotransferase activity. The
intensity of the color is measured in microplate reader
at 450 nm.
Statistical analysis
Data are presented as mean ± standard error. For com-
parison of two groups, a two-tailed t-test was employed
using Excel software. Statistical significance was
assumed when p < 0.05.
Results
Inhibition of TNF-a induced superoxide production
It is well documented that TNF-a induced superoxide
production by NADPH oxidases plays an important role
in inflammatory injury [23]. We have investigated the
effect of mastic gum on TNF-a induced superoxide pro-
duction in cultured RASMC. It has been found that
4-hour treatment of RASMC with TNF-a lead to 2-fold
increase in cellular superoxide (Figure 1A) measured by
accumulation of superoxide specific product of dihy-
droethidium [21]. Supplementation of TNF-a stimulated
cells with mastic gum lead to dose-dependent decrease
in cellular superoxide but did not affect superoxide pro-
duction in unstimulated cells. Interestingly, mastic gum
inhibited not only TNF-a stimulated superoxode pro-
duction but reduced cellular H2O2 (Figure 1B).
These data can be explained by three possible
mechanisms: 1) mastic gum scavenges the superoxide
resulting in lower amount of detectable superoxide; 2)
mastic gum act as superoxide dismutase mimetic which
decreases superoxide detection but does not affect the
amount H2O2; 3) mastic gum inhibits superoxide pro-
duction by affecting cellular sources of superoxide such
as NADPH oxidases. We have investigated all three
mechanisms.
Investigation of superoxide scavenging by mastic gum
Xanthine oxidase and xanthine are commonly used as a
superoxide-generating system [24]. Superoxide produced
by this enzyme can be detected by spin traps such as
EMPO, which produces stable EMPO/*OOH radical
adduct [25]. We have investigated the potential scaven-
ging of superoxide by mastic gum by electron spin
resonance (ESR) with spin trap EMPO.
ESR spectrum of sample containing xanthine oxidase,
xanthine and EMPO revealed typical spectrum of
EMPO/*OOH radical adduct (Figure 2A). Addition of
10 μg/ml and 20 μg/ml mastic gum to xanthine oxidase
superoxide-generating system did not significantly affect
the formation of EMPO/*OOH radical adduct
(Figure 2B, C). Supplementation of xanthine oxidase
superoxide-generating system with 200 μg/ml mastic
gum lead only to small 16% decrease in EMPO/*OOH
ESR signal (Figure 2E). Meanwhile, supplementation of
xanthine oxidase superoxide-generating system with
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[26] or 100 U/ml superoxide dismutase (Figure 2E)
completely abolished the formation of EMPO/*OOH.
These data shows that mastic gum does not have signifi-
cant superoxide scavenging activity.
It is possible that mastic gum does not scavenge
superoxide but stimulates its intracellular dismutation
or interfere with its reaction with dihydroethidium. In
these cases mastic gum should not change the produc-
tion of cellular H2O2. In order to test this hypothesis we
analyzed the production of cellular H2O2 in TNF-a trea-
ted cells by Amplex Red [21]. It was found that mastic
gum inhibited the production of cellular H2O2 in dose
dependent manner (Figure 1B). These data argue that
mastic gum did not scavenge or dismutate superoxide
but actually inhibited the production of cellular reactive
oxygen species.
Inhibition of TNF-a stimulated NADPH oxidase
NADPH oxidases are one of the main sources of cellular
superoxide [27,28]. We have analyzed possible inhibition
of NADPH oxidases by mastic gum. Activity of NADPH
oxidases was determined by NADPH-depended superox-
ide production in the membrane fractions of RASMC
before and after cell stimulation with TNF-a measured
by ESR [22].
It has been found that supplementation of the isolated
membrane fraction with mastic gum did not affect the
basal NADPH oxidase activity (Figure 3A). Treatment of
unstimulated RASMC with mastic gum did not change
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Figure 1 Effect of mastic gum on cellular production of O2* and H2O2. (A) Production of intracellular O2* was measured by DHE following
accumulation of 2-hydroxyethidium using HPLC as described in Materials and Methods [21]. RASMC were stimulated with 20 ng/ml TNF-a for
4-hours. Cells were supplemented with various doses of mastic gum (0-10 μg/ml) for 15-minutes prior to measurements of superoxide.
(B) Production of cellular H2O2 was measured by Amplex Red as described in Materials and Methods [21]. RASMC were stimulated with 20 ng/ml
TNF-a for 4-hours and then supplemented with various doses of mastic gum (0-10 μg/ml) for 15-minutes prior to measurements of H2O2.
*P < 0.01 vs Control, **P < 0.01 vs TNF-a. (C) Superoxide production in bovine aortic endothelial cells (BAEC) stimulated with 200 nM
angiotensin II (Ang II) for 4-hours and treated with mastic gum. Control unstimulated BAEC or Ang II-stimulated BAEC were supplemented with
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TNF-a significantly increased NADPH oxidase activity.
Supplementation of the isolated membrane fraction with
mastic gum did not affect the TNF-a induced NADPH
oxidase activity. Interestingly, treatment of TNF-a stimu-
lated RASMC with mastic gum completely abolished an
activation of NADPH oxidase (Figure 3A). These data
show that mastic gum did not directly inhibited NADPH
oxidase. Mastic gum inhibited TNF-a stimulated
NADPH oxidases only in intact cells and it did not affect
the basal activity. This may suggest that mastic gum may
attenuate activation of NADPH oxidases such as PKC-
mediated phosphorylation of p47phox subunit of
NADPH oxidase [29]. We, therefore, investigated the
effect of mastic gum on stimulation of NADPH oxidase
by PKC activator 12-myristate 13-acetate (PMA) [29,30].
Inhibition of PMA-stimulated NADPH oxidase
Treatment of cells with PMA provides specific PKC-
dependent activation of NADPH oxidases [30]. We
analyzed the effect of mastic gum on PMA-stimulated
superoxide production (Figure 3B). It was found that
mastic gum inhibited PMA-stimulated superoxide pro-
duction in RASMC in dose dependent manner (Figure
3B). Similar to TNF-a induced superoxide production,
10 μg/ml mastic gum completely abolished the PMA-sti-
mulated superoxide production. These data showed that
mastic gum inhibited PKC which attenuates activation
of NADPH oxidase. We suggest that PKC inhibition by
mastic gum is responsible for attenuation of TNF-a
induced oxidative stress.
The PKC Kinase Activity Assay
To determine if mastic gum indeed directly inhibits
PKC we have measured purified PKC activity and PKC
activity in cellular homogenate using ELISA-based PKC
Kinase Activity Assay from Enzo Life Sciences in the
presence of various concentrations of mastic gum. It
was found that activity of purified PKC was inhibited by
mastic gum in the dose dependent manner down to
60% (Figure 4A). PKC activity in homogenate of
PMA-stimulated RASMC was significantly inhibited by
10 μg/ml mastic gum. Interestingly, supplementation of
potent PKC-a and PKC-b inhibitor Go6983 to PMA-
stimulated RASMC inhibited total PKC activity to
similar level as in mastic gum supplemented RASMC
(Figure 4B). These data support the direct inhibition of
PKC by mastic gum.
Inhibition of angiotensin II stimulated
superoxide production
PKC-dependent activation of NADPH oxidases plays an
important role in various pathological conditions asso-
ciated with oxidative stress. Angiotensin II is one of the
key agonists, which stimulates vascular NADPH oxi-
dases via PKC-dependent pathway. In this work we have
investigated the effect of mastic gum on angiotensin II
induced superoxide production in bovine aortic
endothelial cells (Figure 1C). It was found that 4-hour
stimulation of BAEC with angiotensin II significantly
increased cellular superoxide production. Interestingly,
15-minute treatment with mastic gum after angiotensin
II stimulation completely abolished angiotensin II
induced oxidative stress (Figure 1C). These data support
that mastic gum inhibits the production of cellular
superoxide by PKC inhibition.
Discussion
In this work for the first time we report that mastic gum
block TNF-a induced superoxide production. The
decrease in superoxide production was associated with
inhibition of NADPH oxidase in TNF-a stimulated
s m o o t hm u s c l ec e l l s .I th a sb e e nf o u n dt h a ti n h i b i t i o n
of PKC is likely to be responsible for the down
EMPO+XOX
Mastic 10 μg/ml
+ SOD
Mastic 20 μg/ml
Mastic 200 μg/ml D
C
B
A
E
15 G
Figure 2 Spin trapping study of superoxide scavenging by
mastic gum. (A) ESR spectrum of EMPO (60 mM) with xanthine (50
μM) and xanthine oxidase (20 mU/ml); (B) ESR spectrum of (A) plus 10
μg/ml mastic gum; (C) ESR spectrum of (A) plus 20 μg/ml mastic gum;
(D) ESR spectrum of (A) plus 200 μg/ml mastic gum; (E) ESR spectrum of
(A) plus 50 U/ml Cu, Zn-SOD. Computer simulation of ESR spectra
(hyperfine coupling constants a
N =1 3 . 3G ,a
H
b = 10.8 G, a
H
g = 1.1 G) [41]
and inhibition by SOD (E) confirmed detection of EMPO/*OOH radical
adduct. ESR settings were as described in Materials and Methods.
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treated cells. Mastic gum also attenuated superoxide
production in angiotensin II - stimulated endothelial
cells, which strongly support the general antioxidant
activity of mastic gum via inhibition of PKC (Figure 5).
There are different kinds of antioxidants. Many anti-
oxidants are free radical scavengers which react directly
with reactive oxygen species such as ascorbate, vitamin
E, superoxide dismutase and catalase [31]. Other inhibit
the sources of reactive oxygen species, for example,
xanthine oxidase inhibitor allopurinol, NADPH oxidase
inhibitor apocynin, angiotensin II receptor blockers
which attenuate activation of NADPH oxidases [32].
These compounds inhibit production of reactive oxygen
species directly or indirectly. Direct inhibition occurs
due to bind to the source of reactive oxygen species,
while affecting the regulation of these enzymes may pro-
vide indirect inhibition. We suggest that mastic gum
inhibits one of the main cellular sources of superoxide
and H2O2 indirectly by blocking the PKC-dependent
activation of NADPH oxidases (Figure 5).
Protein kinase C plays diverse roles in many cellular
functions, notably proliferation, differentiation, and cell
survival [33]. Members of the PKC family are key signal-
ing mediators in immune responses, and pharmacologi-
cal inhibition of PKC may be useful for treating
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tion of NADPH oxidases is an important step in devel-
opment of oxidative stress in cardiovascular diseases,
diabetes and inflammation [35,36]. However, various
ATP-competitive inhibitors of PKC have problems with
specificity [33]. Interestingly, inflammation induced by
periodontitis has been link to cardiovascular diseases
and it has been associated with PKC-mediated enhanced
oxidative stress [36]. Meanwhile, mastic gum is com-
monly used for treatment of gum diseases such as peri-
odontitis [37], which may partially explain beneficial
effect of mastic gum use.
Mastic gum has been reported to inhibit cell prolifera-
tion and block the cell cycle progression which may be
important in anticancer activity of mastic gum [38].
However, this effect was observed at concentrations of
mastic gum higher that 20 μg/ml, while our data
showed that 1 μg/ml of mastic gum significantly inhib-
ited PKC activity (Figure 4A) and attenuated PMA-sti-
mulated superoxide production (Figure 3B). These data
suggest that mastic gum may affect multiple cellular
targets via PKC dependent pathways.
The chemical structures of mastic gum components
responsible for these activities are not clear. It has been
previously reported that ten triterpenes were identified
in the acidic fraction of mastic gum and 26 triterpenes
were characterized in the neutral fraction [7,8]. It is
interestingly to speculate that inhibition of PKC and
NF-kappaB pathways is associated with triterpene con-
tent rather than minor presence of tocopherol and poly-
phenols because of the lack of significant free radical
scavenging by mastic gum. However, further studies are
required in order to elucidate specific bioactive compo-
nents of mastic gum.
Conclusion
Chios mastic gum has been extensively used for centu-
ries in Mediterranean and Middle Eastern countries,
both as a nutritional supplement and herbal remedy.
Medical trials show that gum mastic may have cytopro-
tective or anti-acid effects on the gastrointestinal system
[4]. Recent studies seem to suggest that gum mastic
may exhibit antibacterial properties [39] and inhibit the
proliferation of androgen-dependent prostate cancer
[40]. This work makes an important addition to this list
demonstrating potential role of antioxidant properties in
the anti-inflammatory activity of the Chios mastic gum
based on inhibition of PKC-dependent NADPH
oxidases.
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